← All companies

TKPH

Takeda Pharmaceutical Company Limited

TKPHF NYSE Pharmaceutical Preparations EDGAR ↗

$35.89

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$55.9B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$26.33 – $39.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 30, 2026 6-K Jul 9, 2026 6-K Jul 8, 2026 6-K Jun 29, 2026 6-K Jun 26, 2026 6-K Jun 24, 2026 6-K Jun 24, 2026 6-K Jun 24, 2026 20-F Jun 17, 2026 6-K Jun 9, 2026 6-K Jun 5, 2026 6-K Jun 5, 2026 6-K Jun 1, 2026 6-K May 26, 2026 6-K May 26, 2026 6-K May 26, 2026 6-K May 26, 2026 6-K May 26, 2026 6-K May 19, 2026 6-K May 13, 2026 6-K May 13, 2026 6-K Mar 30, 2026 6-K Mar 26, 2026 6-K Mar 25, 2026 6-K Mar 2, 2026 6-K Feb 10, 2026 6-K Jan 29, 2026 6-K Dec 18, 2025 6-K Dec 8, 2025 6-K Nov 28, 2025 6-K Oct 30, 2025 6-K Oct 30, 2025 6-K Oct 30, 2025 6-K Oct 1, 2025 6-K Sep 25, 2025 6-K Sep 8, 2025 6-K Jul 31, 2025 6-K Jul 30, 2025 6-K Jul 14, 2025 6-K Jul 9, 2025